Presentation Information
[26PO1-am2-22]Assessing the bleeding risk in patients taking Dabigatran for catheter ablation by using eligibility criteria for large clinical trials of Dabigatran
○Yasuyuki Takashima1,2, Minami Ohira3, Kosuke Doki1,4, Masato Homma1,4 (1. Dept. of Pharm. Sci., Graduate School of Comprehensive Human Sciences, Univ. of Tsukuba, 2. T-CReDO, 3. Aisei Pharmacy Co., Ltd., 4. Dept. of Pharm., Univ. of Tsukuba Hosp.)
Password required to view
A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.